Publication | Open Access

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

Adaptive RadiotherapyRadiation TherapyMedicineOligoprogressive Breast CancerBreast CancerPhase 2Stereotactic Body RadiotherapyOncologyRadiation OncologyLung CancerRadiologyHealth Sciences